| Oct 7 |
Inari Medical to Announce Third Quarter 2024 Financial Results
|
| Sep 17 |
Expert Outlook: Inari Medical Through The Eyes Of 9 Analysts
|
| Sep 13 |
Reasons to Retain Inari Medical Stock in Your Portfolio for Now
|
| Aug 29 |
Inari Medical Announces PEERLESS Data to be Presented During the Late-Breaking Clinical Trial Sessions at TCT 2024
|
| Aug 27 |
Inari updates label of clot removal device linked to 6 deaths
|
| Aug 26 |
FDA Classifies Recall Of Inari Medical's Large Vessel Clot Removal Catheter Device As Most Serious
|
| Aug 26 |
Inari Medical (NARI) Issues Notice Post ClotTriever XL Recall
|
| Aug 21 |
Inari Medical to Present at Upcoming Investor Conferences
|
| Aug 2 |
The Inari Medical, Inc. (NASDAQ:NARI) Second-Quarter Results Are Out And Analysts Have Published New Forecasts
|
| Aug 2 |
Inari promotes Kevin Strange to CFO
|
